Baxter International Inc. (BAX) vs Repligen Corporation (RGEN)
- Baxter International Inc. BAX 25.33 −1.67%
- Repligen Corporation RGEN 175.20 −4.87%
Baxter International Inc. and Repligen Corporation are both Medical Instruments & Supplies companies. Baxter International Inc. is the larger, with a market value of $13.3B against $11.7B — 1.1× the size. Baxter International Inc. has negative trailing earnings, so its P/E is not meaningful; Repligen Corporation trades at 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 5.36%. Repligen Corporation has the higher net margin (5.29% vs −9.27%) and the higher return on invested capital (2.18% vs −1.27%). Across the 21 metrics below, Repligen Corporation leads on 14 and Baxter International Inc. on 7.
Valuation
Profitability
| Metric | BAX | RGEN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 30.08% | 53.52% | 54.29% |
| Operating margin | (2.39%) | 8.23% | 1.07% |
| Net margin | (9.27%) | 5.29% | (1.61%) |
| Free cash flow margin | 7.11% | 14.06% | 1.08% |
| Return on equity | (15.78%) | 1.99% | (1.32%) |
| Return on assets | (5.21%) | 1.42% | 0.00% |
| Return on invested capital | (1.27%) | 2.18% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack